Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 102, Issue 21
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Cardiac risk factors and prevention
Original article
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
Online download statistics by month:
Online download statistics by month: July 2016 to August 2023
Abstract
Full
Pdf
Jul 2016
421
171
47
Aug 2016
1048
414
209
Sep 2016
301
202
77
Oct 2016
1291
243
199
Nov 2016
332
650
98
Dec 2016
184
404
191
Jan 2017
129
167
50
Feb 2017
18
105
40
Mar 2017
17
291
49
Apr 2017
10
210
41
May 2017
8
186
29
Jun 2017
27
124
30
Jul 2017
117
115
26
Aug 2017
124
99
17
Sep 2017
123
98
19
Oct 2017
93
89
21
Nov 2017
189
161
9
Dec 2017
186
147
18
Jan 2018
163
118
15
Feb 2018
189
142
15
Mar 2018
514
422
30
Apr 2018
473
459
30
May 2018
286
242
23
Jun 2018
211
193
47
Jul 2018
194
144
37
Aug 2018
257
241
20
Sep 2018
238
222
14
Oct 2018
333
311
19
Nov 2018
573
371
27
Dec 2018
368
348
16
Jan 2019
322
255
25
Feb 2019
239
217
25
Mar 2019
144
108
17
Apr 2019
138
76
24
May 2019
159
120
40
Jun 2019
99
75
24
Jul 2019
82
55
12
Aug 2019
127
101
20
Sep 2019
114
92
17
Oct 2019
105
95
10
Nov 2019
179
99
21
Dec 2019
86
76
14
Jan 2020
91
78
25
Feb 2020
141
94
20
Mar 2020
167
164
20
Apr 2020
80
74
17
May 2020
61
57
15
Jun 2020
51
40
13
Jul 2020
45
42
33
Aug 2020
314
291
22
Sep 2020
74
35
12
Oct 2020
94
52
17
Nov 2020
101
55
28
Dec 2020
91
49
10
Jan 2021
104
73
22
Feb 2021
95
63
15
Mar 2021
108
76
15
Apr 2021
235
192
22
May 2021
82
68
21
Jun 2021
59
59
19
Jul 2021
43
43
14
Aug 2021
66
66
20
Sep 2021
55
55
17
Oct 2021
92
60
32
Nov 2021
136
101
24
Dec 2021
125
86
21
Jan 2022
100
52
5
Feb 2022
154
85
24
Mar 2022
126
82
24
Apr 2022
315
131
21
May 2022
203
71
27
Jun 2022
145
85
19
Jul 2022
143
47
10
Aug 2022
95
66
16
Sep 2022
84
74
18
Oct 2022
110
72
20
Nov 2022
71
48
20
Dec 2022
72
46
12
Jan 2023
174
99
22
Feb 2023
135
72
26
Mar 2023
138
46
15
Apr 2023
73
53
14
May 2023
61
51
23
Jun 2023
91
65
9
Jul 2023
85
74
32
Aug 2023
47
46
12
Total
15143
11796
2555
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?